Virustatic is a UK biotech firm. Our mission is to find lifesaving alternatives in an antibiotic resistant world. Our technology has numerous applications across many sectors. We united a team of scientific partners and facilities to help combat a real and growing threat from the spread of infections. And we have worked closely with world leading scientists for several years to make sure our research and development is world class. The Virustatic team has developed an antiviral protein coating, Viruferrin™, which has not only been proven effective against live influenza viruses but is now scientifically proven to bind to SARS-CoV-2, the virus strain that causes the current COVID-19 pandemic.
Virustatic is a UK biotech firm. Our mission is to find lifesaving alternatives in an antibiotic resistant world. Our technology has numerous applications across many sectors. We united a team of scientific partners and facilities to help combat a real and growing threat from the spread of infections. And we have worked closely with world leading scientists for several years to make sure our research and development is world class. The Virustatic team has developed an antiviral protein coating, Viruferrin™, which has not only been proven effective against live influenza viruses but is now scientifically proven to bind to SARS-CoV-2, the virus strain that causes the current COVID-19 pandemic.
Company Information
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- M-SParc Gaerwen
- City
- Adlington
- Region
- Cheshire
- Postal Code
- LL60 6AG
- Country
- United Kingdom